Cargando…
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
There is increasing evidence that oncogenic transformation modifies the metabolic program of cells. A common alteration is the upregulation of glycolysis, and efforts to target glycolytic enzymes for anti-cancer therapy are underway. Here, we performed a genome-wide haploid genetic screen to identif...
Autores principales: | Birsoy, Kivanc, Wang, Tim, Possemato, Richard, Yilmaz, Omer H., Koch, Catherine E., Chen, Walter W., Hutchins, Amanda W., Gultekin, Yetis, Peterson, Tim R., Carette, Jan E., Brummelkamp, Thijn R., Clish, Clary B., Sabatini, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530647/ https://www.ncbi.nlm.nih.gov/pubmed/23202129 http://dx.doi.org/10.1038/ng.2471 |
Ejemplares similares
-
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
por: Birsoy, Kıvanç, et al.
Publicado: (2014) -
A Reporter Screen in a Human Haploid Cell Line Identifies CYLD as a Constitutive Inhibitor of NF-κB
por: Lee, Clarissa C., et al.
Publicado: (2013) -
mTORC1 in the Paneth cell niche couples intestinal stem cell function to calorie intake
por: Yilmaz, Ömer H., et al.
Publicado: (2012) -
Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan
por: Lamming, Dudley W, et al.
Publicado: (2014) -
MCT4 is an important determinant for the growth of highly glycolytic and aggressive malignancies
por: Unsal-Kacmaz, Kezi, et al.
Publicado: (2012)